Asirvatham Ananthi J, Gregorie Christopher J, Hu Zihua, Magner William J, Tomasi Thomas B
Laboratory of Molecular Medicine, Department of Immunology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Mol Immunol. 2008 Apr;45(7):1995-2006. doi: 10.1016/j.molimm.2007.10.035. Epub 2007 Dec 3.
We studied 613 genes which regulate immunity and, utilizing predictive algorithms, identified 285 genes as microRNA (miRNA or miR) targets. Of these, approximately 250 are newly predicted gene-miR interactions. The frequency of predicted miRNA binding sites in immune gene 3'UTRs indicated preferential targeting of immune genes compared to the genome. Major targets include transcription factors, cofactors and chromatin modifiers whereas upstream factors, such as ligands and receptors (cytokines, chemokines and TLRs), were, in general, non-targets. About 10% of the immune genes were 'hubs' with eight or more different miRNAs predicted to target their 3'UTRs. Hubs were focused on certain key immune genes, such as BCL6, SMAD7, BLIMP1, NFAT5, EP300 and others. NF-kappaB and p53 do not themselves have binding sites for miRNAs but rather these pathways are targeted by miRNAs at downstream sites. MHC class II genes lacked miRNA targets but binding sites were identified in the CIITA gene and were shown experimentally to repress IFN-gamma-induced MHC class II activation. Unexpectedly, factors involved in regulating message stability via AU-rich elements (ARE) were heavily targeted. Moreover, multiple components involved in the generation and effector functions of miRNAs (Dicer and Argonautes) were themselves miRNA targets suggesting that a subset of miRNAs may indirectly control their own production as well as other miRNAs.
我们研究了613个调节免疫的基因,并利用预测算法,鉴定出285个基因为微小RNA(miRNA或miR)的靶标。其中,约250个是新预测的基因-miR相互作用。免疫基因3'非翻译区(UTR)中预测的miRNA结合位点频率表明,与基因组相比,免疫基因存在优先靶向。主要靶标包括转录因子、辅因子和染色质修饰因子,而上游因子,如配体和受体(细胞因子、趋化因子和Toll样受体)通常不是靶标。约10%的免疫基因是“枢纽”基因,预测有8个或更多不同的miRNA靶向其3'UTR。枢纽基因集中在某些关键免疫基因上,如BCL6、SMAD7、BLIMP1、NFAT5、EP300等。核因子κB(NF-κB)和p53自身没有miRNA结合位点,而是这些信号通路在下游位点被miRNA靶向。MHCⅡ类基因缺乏miRNA靶标,但在CIITA基因中鉴定到了结合位点,并且实验表明其可抑制干扰素-γ诱导的MHCⅡ类激活。出乎意料的是,通过富含AU元件(ARE)调节信使稳定性的因子成为主要靶标。此外,参与miRNA生成和效应功能的多个组分(Dicer和AGO蛋白)自身也是miRNA靶标,这表明一部分miRNA可能间接控制自身的产生以及其他miRNA。